Tiziana Life Sciences is trading 5.1% up at $1.04 in after-hours trading, extending a recent recovery driven by a technical rebound and broader strength across the biotechnology sector.
- The stock closed the regular session at $0.99 following a sharp 6.4% gain on August 5, 2026.
- The upward move comes despite no new company-specific news or earnings reports being released after the market close.
- The price action reflects a continuation of the rebound seen in the broader biotech market.